Order Article Reprints

Yamashita Y, Morita S, Hosoi H, Kobata H, Kishimoto S, Ishibashi T, Mishima H, Kinoshita A, Backes BJ, Yoshiura K-I, et al. Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib. International Journal of Molecular Sciences. 2020; 21(17):6314. https://doi.org/10.3390/ijms21176314

Yamashita, Yusuke, Shuhei Morita, Hiroki Hosoi, Hiroshi Kobata, Shohei Kishimoto, Tatsuya Ishibashi, Hiroyuki Mishima, Akira Kinoshita, Bradley J. Backes, Koh-Ichiro Yoshiura, and et al. 2020. "Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib" International Journal of Molecular Sciences 21, no. 17: 6314. https://doi.org/10.3390/ijms21176314

Yamashita, Y., Morita, S., Hosoi, H., Kobata, H., Kishimoto, S., Ishibashi, T., Mishima, H., Kinoshita, A., Backes, B. J., Yoshiura, K.-I., Papa, F. R., Sonoki, T., & Tamura, S. (2020). Targeting Adaptive IRE1α Signaling and PLK2 in Multiple Myeloma: Possible Anti-Tumor Mechanisms of KIRA8 and Nilotinib. International Journal of Molecular Sciences, 21(17), 6314. https://doi.org/10.3390/ijms21176314